Ameriprise’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,133
| Closed | -$76.3K | – | 4062 |
|
|
2024
Q4 | $76.3K | Buy |
2,133
+307
| +17% | +$11K | ﹤0.01% | 3952 |
|
|
2024
Q3 | $86.3K | Buy |
1,826
+4
| +0.2% | +$189 | ﹤0.01% | 3835 |
|
|
2024
Q2 | $91.5K | Buy |
1,822
+1,106
| +154% | +$55.6K | ﹤0.01% | 3782 |
|
|
2024
Q1 | $80.2K | Sell |
716
-924
| -56% | -$104K | ﹤0.01% | 3793 |
|
|
2023
Q4 | $95.1K | Buy |
+1,640
| New | +$95.1K | ﹤0.01% | 3820 |
|
|
2023
Q3 | – | Sell |
-22,891
| Closed | -$1.88M | – | 3936 |
|
|
2023
Q2 | $1.88M | Buy |
+22,891
| New | +$1.88M | ﹤0.01% | 2901 |
|
|
2023
Q1 | – | Sell |
-1,082
| Closed | -$158K | – | 4003 |
|
|
2022
Q4 | $158K | Sell |
1,082
-13
| -1% | -$1.9K | ﹤0.01% | 3744 |
|
|
2022
Q3 | $185K | Buy |
+1,095
| New | +$185K | ﹤0.01% | 3720 |
|
|
2021
Q1 | – | Sell |
-337
| Closed | -$225K | – | 3869 |
|
|
2020
Q4 | $225K | Buy |
+337
| New | +$225K | ﹤0.01% | 3591 |
|
|
2019
Q4 | – | Sell |
-779
| Closed | -$31K | – | 3736 |
|
|
2019
Q3 | $31K | Sell |
779
-816
| -51% | -$32.5K | ﹤0.01% | 3670 |
|
|
2019
Q2 | $161K | Buy |
+1,595
| New | +$161K | ﹤0.01% | 3596 |
|